In a novel approach to heart failure, a soft robotic device that compresses the ventricle with soft actuators while anchoring to the septum was successful in a pig model, researchers reported in Science Robotics.
Newer-generation transcatheter aortic valve replacement devices had better procedural outcomes, including less postprocedural aortic regurgitation and lower 1-year mortality, compared with early-generation devices in a registry study reported in the Journal of the American College of Cardiology (JACC).
Telemedicine and telehealth services payments by Medicaid will be audited by the Department of Health and Human Services’ Office of the Inspector General, adding to an audit of Medicare Part B telehealth payments. (FierceHealthcare)
The American College of Cardiology and Heart Rhythm Society released a statement on competencies required of clinical cardiac electrophysiology specialists atop the basic training in cardiac electrophysiology required of all trainees during the standard 3-year cardiovascular fellowship.
The ACC also released a consensus document on managing acute bleeding in patients on oral anticoagulants. (JACC)
The New York Times has a consumer consideration of competing claims on dietary sodium reduction in its “Well” blog, which sides with cutting intake. (Subscription required)
The DPP-4 inhibitor class of type 2 diabetes drugs might have a different effect on cardiovascular outcomes depending on whether it’s combined with metformin, according to a meta-analysis in Diabetes Care showing a trend for benefit in combination but trend for harm with a DPP-4 alone.
NaviGate Cardiac Structures touted resolution of tricuspid regurgitation at 6 weeks in two patients who got its Gate transcatheter tricuspid atrioventricular valved stent under compassionate use.
The FDA cleared the Imris and Hill-Rom MRI-conditional surgical table for use in hybrid operating rooms and the EluNIR ridaforolimus-eluting coronary stent, according to their respective manufacturers.
Cerebrotech said European regulators granted marketing authorization for its Intracranial Fluids Monitor bioimpedance spectroscopy device in detection of stroke-related brain changes.